Risk Disclosure
Explicitly list known and foreseeable risks associated with participation, including physical, privacy, and reputational risks; explain mitigation measures and clarify that not all risks can be eliminated.
Use an Evaluation Participation Waiver to reduce legal uncertainty, document informed consent, and allocate risk between participants and organizers. It clarifies data handling, confidentiality, and IP terms, helping evaluators manage liability and participants understand responsibilities during testing or assessment.
Common users include organizations running product tests, researchers conducting studies, and vendors offering pilot programs to external participants.
Smaller organizations and legal teams also use the waiver to standardize participant terms and streamline review processes.
Explicitly list known and foreseeable risks associated with participation, including physical, privacy, and reputational risks; explain mitigation measures and clarify that not all risks can be eliminated.
State the scope of the release, naming parties released, time limitations, and any exclusions for gross negligence or willful misconduct, where permitted by law.
Specify categories of data collected, permitted uses, sharing with third parties, anonymization steps, and retention periods to ensure compliance with privacy obligations, including security controls and purpose limitation.
Clarify ownership of feedback, inventions, or improvements made during evaluation; specify license back to organizer if participant retains rights for future product development.
Define monetary payments, reimbursements, or benefits, timing, tax reporting responsibilities, and whether compensation ceases upon early termination or withdrawal and methods for dispute resolution.
Provide for participant signature, date, and representative signature if applicable; include witness or notary blocks when state law or institutional policy requires additional authentication and attach signed audit trail.
| Field | Configuration |
|---|---|
| Signer Role | Assign participant and organization roles with signing order. |
| Authentication | Email link or SMS code; consider KBA for high-risk evaluations. |
| Conditional Fields | Show follow-up questions when participant indicates prior exposure or special conditions. |
| Retention Settings | Set archive duration and export formats to meet retention policy. |
Digital execution is common for Evaluation Participation Waivers; confirm platform security, signer authentication, and record retention before deployment.
Date the waiver is signed and becomes operative.
Date and local time the evaluation begins.
Date when participant activities end and data collection stops.
Deadline for deleting or archiving participant data per retention policy.
Timeframe to notify participants of renewals or material changes.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | Yes, 7-day trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | No cap | No cap | No cap |